BRADLEY PHARMACEUTICALS CFO TO RESIGN
BRADLEY PHARMACEUTICALS CFO TO RESIGN FAIRFIELD, N.J., /PRNewswire/ -- Bradley Pharmaceuticals, Inc.
(NASDAQ: BPRXA) announced today that Richard L. Audet will resign as chief financial officer and a director of the company. Audet will therefore not be standing for re-election as a director at the annual meeting of shareholders to be held on May 29, 1992. The board of directors of the company has not yet selected a substitute nominee but expects to fill the vacancy left by Audet during the next several months in accordance with the company's by-laws in the event a substitute nominee is not chosen prior to the annual meeting.
Bradley Pharmaceuticals, Inc. markets and distributes over-the- counter and prescription pharmaceutical and health related products. -0- 5/21/92 /CONTACT: Daniel Glassman of Bradley Pharmaceuticals, 201-882-1505/ (BPRXA) CO: Bradley Pharmaceuticals, Inc. ST: New Jersey IN: MTC SU: PER
LR -- NY093 -- 3008 05/21/92 15:58 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||May 21, 1992|
|Previous Article:||DOUGLAS & LOMASON RESUMES REGULAR QUARTERLY DIVIDEND|
|Next Article:||ULTIMAP CORPORATION ADDS SEVEN NEW EMPLOYEES|